K213197

Substantially Equivalent

MyOnyx System

Applicant: Thought Technology , Ltd.
Product code: IPF
Advisory panel: Physical Medicine
Date received: 2021-09-29
Decision date: 2022-06-17
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Montreal, CA

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.